Great Point Partners LLC Exelixis, Inc. Transaction History

Great Point Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $22.7 Million - $30.1 Million	-1,300,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $7.66 Million - $10.2 Million	-450,000 Reduced 25.71%	1,300,000 $29.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $3.56 Million - $4.92 Million	225,000 Added 14.75%	1,750,000 $32 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $2.13 Million - $2.77 Million	130,893 Added 9.39%	1,525,000 $32.2 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $3.46 Million - $4.93 Million	193,007 Added 16.07%	1,394,107 $25.4 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $14.9 Million - $18.3 Million	726,100 Added 152.86%	1,201,100 $27.1 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $8.74 Million - $11.8 Million	475,000 New	475,000 $9.53 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $4.69 Million - $5.85 Million	-309,700 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$17.68 - $22.65 $5.48 Million - $7.01 Million	309,700 New	309,700 $5.48 Million
Q4 2018 Feb 15, 2019	SELL	$13.65 - $21.8 $28.3 Million - $45.2 Million	-2,075,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $11.7 Million - $16.6 Million	740,207 Added 55.45%	2,075,000 $36.8 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $8.07 Million - $9.76 Million	434,893 Added 48.33%	1,334,793 $28.7 Million
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $19.9 Million - $28.7 Million	899,900 New	899,900 $0

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.